NovaBridge Biosciences NBP
NASDAQ NBP
$1.36 +0.02 (+1.49%)
At close: Oct 2, 2026 · 4:00 PM EDT

NovaBridge Biosciences (NBP) Depreciation and Depletion (2019 - 2025)

Updated

NovaBridge Biosciences (NBP) reported Depreciation and Depletion of $15,000 for Q4 2025, down 31.8% from $22,000 a year earlier and down 11.8% from the prior quarter.

Analysis

NovaBridge Biosciences (NBP) Depreciation and Depletion (2019 - 2025) Analysis & Trends

For FY2025, NovaBridge Biosciences posted Depreciation and Depletion of $68,000, down 73.9% from FY2024.

  • Depreciation and Depletion has a five-year compound annual growth rate of -48.9% (FY2020 to FY2025).
  • By year, Depreciation and Depletion came in at $261,000 in FY2024 (-45.1%), $475,000 in FY2023 (+130.6%), $206,000 in FY2022 (-90.5%) and $2.16 million in FY2021 (+10.7%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Depletion (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 194.00 Mn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 98.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 NovaBridge Biosciences 149.78 Mn 149.78 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 15,000.00
Sep 30, 2025 17,000.00
Dec 31, 2024 22,000.00
Sep 30, 2024 20,000.00
Dec 31, 2020 755,220.95
Sep 30, 2020 382,291.49
Dec 31, 2019 425,074.79
API Access

NovaBridge Biosciences Depreciation and Depletion API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-depletion&ticker=NBP&period=max&api_key=YOUR_API_KEY